Biocon plan to open a training campus for graduates
Biocon the Biopharma major is planning to set up an academic institution called Biocon Academy next financial year.
BIOCON
Biocon in drug marketing deal with Pfizer
The world’s top drug maker Pfizer said that it has entered into a deal to sell drug maker Biocon Ltd’s biosimilar versions of diabetes treatment insulin.
Biocon partners Teleradiology Solutions to accelerate drug discovery process
Biocon, India’s largest biotechnology company, entered into an agreement with Teleradiology Solutions, a pioneer of the domain in India, to provide teleradiology reporting services to Clinigene, Biocon’s Clinical Research Organisation.
Biocon plunges into profit in the third quarter
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Biocon and HCG Group of Hospitals Ltd. Join Hands to Fight Against Cervical Cancer
Biocon and HCG group of hospitals have announced their partnership to conduct a study to uate the potential benefits of BIOMAb EGFR
Pharma cos recast European operations to protect margins
Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of changing trends in the key market.
Needle-free insulin soon in India
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
